Agree Teva comparison is not a good one . Their debt is now higher than their market cap and they will most likely breach debt covenants. Myx management were conservative in funding the teva portfolio with equity. 232 m net debt in Dec after a big spend on inventories . You would expect net debt at 200m of less now and I would expect Forward EBITDA at circa 195-205.
I would love to see them pay down debt for a few more months and then try and pick up some more Teva assets even if it meant raising equity at these levels.
Fundamentals Are Strong, page-817
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.88 |
Change
-0.010(0.20%) |
Mkt cap ! $415.1M | |||
| Open | High | Low | Value | Volume |
| $4.96 | $4.97 | $4.74 | $916.4K | 188.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 986 | $4.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.90 | 540 | 1 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| MYX (ASX) Chart |